These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16123696)

  • 1. Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?
    Patel D; Thorne C; Fiore S; Newell ML;
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):116-8. PubMed ID: 16123696
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.
    Bussmann H; Wester CW; Wester CN; Lekoko B; Okezie O; Thomas AM; DeGruttola SM; Makhema J; Essex M; Marlink RG
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):269-73. PubMed ID: 17450102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
    Martin F; Taylor GP
    J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antiretroviral therapy during pregnancy and risk of congenital malformations.
    Frieden IJ; Haggstrom AN; McCulloch C; Drolet B; Esterly NB; Garzon MC; Lucky AW; Baselga E; Friedlander SF
    JAMA; 2004 Apr; 291(16):1961-2; author reply 1962. PubMed ID: 15113813
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero.
    De Santis M; Cavaliere AF; Caruso A; Villa P; Tamburrini E; Cauda R; Fundaro C; Genovese O
    JAMA; 2004 Jan; 291(3):305. PubMed ID: 14734592
    [No Abstract]   [Full Text] [Related]  

  • 7. Pregnancies in perinatally HIV-infected women: antiretroviral treatment strategies, obstetric and virologic outcomes.
    Cecchini D; Martinez M; Verdi Brusati F; Rodriguez C
    Rev Esp Quimioter; 2018 Jun; 31(3):291-292. PubMed ID: 29791125
    [No Abstract]   [Full Text] [Related]  

  • 8. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
    Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.
    Townsend CL; Willey BA; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2009 Feb; 23(4):519-24. PubMed ID: 19165088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of low birthweight infants in HIV-infected women delivered in Rajavithi Hospital.
    Asavapiriyanont S; Kasiwat S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S66-70. PubMed ID: 21717881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.
    Li N; Sando MM; Spiegelman D; Hertzmark E; Liu E; Sando D; Machumi L; Chalamilla G; Fawzi W
    J Infect Dis; 2016 Apr; 213(7):1057-64. PubMed ID: 26265780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?
    Jungmann EM; Mercey D; DeRuiter A; Edwards S; Donoghue S; Booth T; Mohan D; Lyall H; Taylor GP
    Sex Transm Infect; 2001 Dec; 77(6):441-3. PubMed ID: 11714944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
    Ford N; Calmy A; Mofenson L
    AIDS; 2011 Nov; 25(18):2301-4. PubMed ID: 21918421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efavirenz (Sustiva) in pregnancy: a study about 12 HIV patients].
    Jeantils V; Khuong MA; Delassus JL; Honoré P; Taverne B; Uzan M; Tassi S
    Gynecol Obstet Fertil; 2006; 34(7-8):593-6. PubMed ID: 16814587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    Hernández S; Catalán-García M; Morén C; García-Otero L; López M; Guitart-Mampel M; Milisenda J; Coll O; Cardellach F; Gratacós E; Miró Ò; Garrabou G
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e113-e119. PubMed ID: 28234688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
    Machado ES; Hofer CB; Costa TT; Nogueira SA; Oliveira RH; Abreu TF; Evangelista LA; Farias IF; Mercadante RT; Garcia MF; Neves RC; Costa VM; Lambert JS
    Sex Transm Infect; 2009 Apr; 85(2):82-7. PubMed ID: 18987014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth defect rates unchanged by antiretrovirals.
    AIDS Patient Care STDS; 2007 Jun; 21(6):436. PubMed ID: 17594253
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.